Ophthalmology

Headache Relief Shampoo Voted #1 Best New Product in 2019

Dr. D’s Medicated Headache Relief Shampoo is now available. This medicated shampoo will help alleviate headaches simply by soaking it on your head. Finding relief from minor to severe headaches shouldn’t always involve reaching for a bottle of pills. Dr. D is here to give you another option. Our proprietary formula will leave your head feeling better.

BUY NOW! http://headachereliefshampoo.com/product/headache-relief-shampoo/

January 1, 2019 / by / in
A Study Assessing the Safety, Tolerability, and Efficacy of RO7171009 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Conditions:   Macular Degeneration, Age-Related;   Geographic Atrophy
Interventions:   Drug: RO7171009;   Drug: Sham Control
Sponsor:   Genentech, Inc.
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 4, 2019 / by / in
ReCLAIM-2 Study to Evaluate Safety,Efficacy & Pharmacokinetics of Elamipretide in Subjects With AMD With GA

Condition:   Age-related Macular Degeneration
Interventions:   Combination Product: Subcutaneous elamipretide through the elamipretide delivery system;   Combination Product: Subcutaneos placebo through the elamipretide delivery system
Sponsor:   Stealth BioTherapeutics Inc.
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 20, 2019 / by / in
Nailfold Capillary Blood Flow With Latanoprost Bunod

Condition:   Glaucoma, Open-Angle
Interventions:   Drug: Latanoprost 0.005%;   Drug: Latanoprost bunod 0.024%;   Drug: Normal saline 0.9%;   Diagnostic Test: Nailfold capillaroscopy
Sponsor:   Icahn School of Medicine at Mount Sinai
Not yet recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 14, 2019 / by / in
Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves’ Ophthalmopathy ( GO )

Condition:   Graves’ Ophthalmopathy (GO)
Interventions:   Drug: RVT-1401 (Administered via subcutaneous injection);   Other: Placebo (Administered via subcutaneous injection)
Sponsor:   Immunovant Sciences GmbH
Not yet recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 6, 2019 / by / in
Study Comparing the Effects of Latanoprostene Bunod and Timolol on Retinal Blood Vessel Density and Visual Acuity

Conditions:   OAG – Open-Angle Glaucoma;   OHT – Ocular Hypertension
Interventions:   Drug: Latanoprostene bunod 0.024% QD;   Drug: Timolol maleate 0.5% BID
Sponsors:   University of California, San Diego;   Bausch & Lomb Incorporated
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 30, 2019 / by / in
A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema

Condition:   Diabetic Macular Edema
Interventions:   Device: Retilux;   Device: Sham Light Device
Sponsors:   Jaeb Center for Health Research;   National Institutes of Health (NIH);   National Eye Institute (NEI);   Juvenile Diabetes Research Foundation;   PhotoOptx LLC
Recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

April 25, 2019 / by / in
Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED)

Condition:   Dry Eye
Interventions:   Drug: SDP-4 Ophthalmic Solution (0.1%);   Drug: SDP-4 Ophthalmic Solution (1.0%);   Drug: SDP-4 Ophthalmic Solution (3.0%);   Drug: Vehicle
Sponsor:   Silk Technologies, Ltd.
Not yet recruiting
ClinicalTrials.gov: Ophthalmology | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

March 27, 2019 / by / in